Dr. Erica Jordyn Weinstein, MD

Dr. Weinstein practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Weinstein's NPI, 1801281340, was assigned on April 1, 2015. Dr. Weinstein graduated from Albert Einstein College of Medicine of Yeshiva University in 2015. Dr. Weinstein holds Pennsylvania license MD470176.

Dr. Weinstein's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Weinstein's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Weinstein is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Weinstein to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinstein practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Weinstein's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Weinstein is licensed in Pennsylvania.

CMS data shows 256 Medicare services from Dr. Weinstein across 7 procedure codes in 2024, for 91 Medicare patients. Medicare paid $20,819 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Weinstein in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weinstein's median patient age at 58, with 35% women.

In 2024, Dr. Weinstein wrote 229 Medicare Part D claims for 46 patients. 77% of them were for generic drugs. CMS names the drug for 179 of them, across 8 drugs with 11 or more claims each, at $654,060 in total drug cost. In 2023, CMS named 62 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Weinstein for performance year 2024, reported as part of a group. Dr. Weinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weinstein as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Weinstein, published from 2014 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Algorithms, Analgesia and Anesthesia, Conduction. Dr. Weinstein has published most often in Open Forum Infect Dis. Dr. Weinstein's most frequent co-authors are Doerthe Adriana Andreae, MD, Marc Samuel Cohen, MD, MS and Randi S. Silibovsky, MD.

CMS Open Payments shows 2 general payments to Dr. Weinstein from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $41.

Dr. Weinstein graduated from Albert Einstein College of Medicine of Yeshiva University in 2015.